Background: Recent studies suggest that Mincle expression is induced by Dectin-3-mediated signaling in response to TDM stimulation. Results: Deficiency in Dectin-3 and the CARD9-Bcl10-Malt1 complex are defective for TDM-induced NF-B activation and Mincle. Conclusion: Dectin-3-and CARD9/Bcl10/Malt1-dependent NF-B activation plays an essential role for TDM-induced Mincle expression. Significance: This study provides the molecular insight for designing adjuvants that stimulate the immune system.
The C-type lectin receptors (CLRs) 3 are a large superfamily of proteins that contain a carbohydrate recognition domain and calcium-binding sites on their extracellular domains (1) (2) (3) . The Dectin-2 family of CLRs encoded by the natural killer gene cluster is composed of Dectin-2, Dectin-3 (originally named murine macrophage C-type lectin, MCL, and also classified as CLECSF8 or Clec4d), BDCA-2 (blood dendritic cell antigen 2), Mincle, and DCIR (dendritic cell immunoreceptor) (4, 5) . These CLRs are type II transmembrane receptors and share a common structure consisting of a single extracellular C-type lectin-like domain, a stalk region of varying length, and a transmembrane region (6) .
Interestingly, Mincle is a recently characterized receptor for macrophage recognition of Mycobacterium tuberculosis, which recognizes the Mycobacterium cord factor, trehalose-6,6Ј-dimycolate (TDM) (7) (8) (9) (10) (11) . Mincle is important for macrophageassociated innate immune response (12, 13) , as well as in vitro macrophage activation (14) . Furthermore, Mincle-deficient mice show defective adaptive immune responses to immunization with a synthetic TDM analog (11, 15, 16) .
Emerging evidence indicate that upon ligand binding, CLRs, such as Dectin-1, Dectin-2, Mincle, DCAR, and BDCA-2, induce multiple signal transduction cascades through their own immunoreceptor tyrosine-based activation motifs or interacting with immunoreceptor tyrosine-based activation motif-containing adaptor proteins such as FcR␥ (5, 17) . These CLR-induced signaling cascades lead to the activation of nuclear factor B (NF-B) family of transcriptional factors through a Syk-and CARD9-dependent pathway (9, 18, 19) . The activation of NF-B plays a critical role in the induction of innate immune and inflammatory responses following microbial infection and tissue damages (18, 20, 21) . Dectin-3, which has a short cytoplasmic tail without any signaling motif and is presumably associated with other signaling adaptors, is the least characterized member of this family (22, 23) . We have recently demonstrated that Dectin-3 forms a heterodimeric pattern-recognition receptor with Dectin-2 for sensing fungal infection through activation of NF-B (24) .
In a recent study, Dectin-3/MCL was identified as another receptor for TDM (25) . Moreover, Lobato-Pascual et al. found that Mincle can form a receptor complex with Dectin-3 and Fc⑀RI-␥ in a rat system (26) . It is interesting to know whether Dectin-3 and Mincle are functionally linked for the recognition of TDM. In this study, we report that Dectin-3-mediated NF-B activation is critical for TDM-induced Mincle expression, which is dependent on the CARD9-Bcl10-MALT1 complex. Although Dectin-3 has been found to form a heterodimeric complex with Dectin-2, only Dectin-3, but not Dectin-2, is required for induction of Mincle. In addition, Dectin-3 neither form a heterodimeric complex nor synergistically induce NF-B activation with Mincle. Instead, it only serves as a sensor for induction of Mincle. Functionally, we showed that Dectin-3-deficient mice, as CARD9-deficient mice, produce much less cytokines and antigen-specific antibodies when using the adjuvant containing TDM.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents-Antibodies against phospho-p38 (4631), phospho-ERK (9101), phospho-JNK (9251), phospho-IKK (2697), total p38 (9212), and total JNK (9252) were purchased from Cell Signaling Technology; antibodies against p65 (sc-8008), proliferating cell nuclear antigen (sc-56), NFAT-c1 (sc-7294), ERK (sc-154), IKK␣ (sc-7218), IB␣ (sc-371), FLAG (sc-807), and tubulin (sc-8035) were from Santa Cruz Biotechnology. TDM (catalog no. T3034) and TPCA-1 (T1452) were from Sigma. In all experiments, TDM was coated in six-well plate with 20 g/ml concentration at 4°C for overnight. NFAT inhibitor 11R-VIVIT (catalog no. 13855) was from Cayman Chemical. Dectin-2 and Dectin-3 monoclonal antibodies (IgG1 and IgG2a) were generated by using the extracellular domain of Dectin-2 or Dectin-3 as immunogens that were described previously (24) . Monoclonal antibodies against Mincle were generated by using the extracellular domain of Mincle as immunogens. Fluorescence-conjugated monoclonal antibodies CD11b (catalog no. 45-0112-82) and F4/80 (catalog no. 123108) were purchased from eBioscience and Biolegend. FITC-conjugated goat anti-mouse IgG (HϩL) secondary antibody was purchased from Invitrogen (catalog no. 62-6511).
Plasmid Construction-Human Dectin-2, Dectin-3, and Mincle were amplified by PCR using full-length cDNA of human peripheral blood cells as a template (24) . All PCR amplifying fragments including FLAG-encoding DNA sequence were inserted into the SalI and BglII digested site of pRV3 (a lentiviral vector).
Mice-Dectin-3-knock-out (Clec4d Ϫ/Ϫ ) mice, CARD9knock-out (Card9 Ϫ/Ϫ ) mice, Bcl10 knock-out (Bcl10 Ϫ/Ϫ ) mice and Malt1 knock-out (Malt1 Ϫ/Ϫ ) mice have been described previously (20, 24, 27, 28) . All mice were housed in the specific pathogen-free animal facility at MD Anderson Cancer Center. 8-to 16-week-old mice were used in the experiments. All animal experiments were performed in compliance with institutional guidelines and according to the protocol approved by the Institutional Animal Care and Use Committee of The University of Texas MD Anderson Cancer Center.
Immunization of mice was conducted as described previously (29 -31) . Briefly, CARD9-and Dectin-3-deficient mice and their controls (7-week-old female mice) were immunized with keyhole limpet hemocyanin (KLH, 0.5 mg/ml) emulsified in complete Freund's adjuvant (0.5 mg/ml) at the base of the tail (100 l for each mouse). Forty-eight hour later, blood was collected from the tail and measured for cytokine production. Seven days after immunization, mice were sacrificed, and serum samples were subjected to immunoglobulin analysis by ELISA. In brief, different dilutions of serum were added into wells of plates precoated with KLH protein (10 g/ml), and antigen-specific antibodies were detected with biotinylated anti-mouse IgG, HRP-conjugated goat anti-mouse IgM, goat anti-mouse IgG1-HRP, and goat anti-mouse IgG2a-HRP antibodies (Southern Biotechnology Associates).
BMDM Preparation-Primary cultures of bone marrow-derived macrophages (BMDMs) from C57BL/6J mice were prepared as described previously (24, 32) . Briefly, bone marrow cells were harvested from the femurs and tibias of mice. Erythrocytes were removed from cells by using a hypotonic solution. Cells were cultured for 7 days in Dulbecco's modified Eagle's medium containing 20% fetal bovine serum, 55 M ␤-mercaptoethanol, streptomycin (100 g/ml), penicillin (100 units/ml), and 30% conditioned medium from L929 cells expressing macrophage colony-stimulating factor. Non-adherent cells were removed, and cells were passed every 3 days. After 1 week of culturing, flow cytometry analysis indicated that the harvested cell population contained above 97% CD11b ϩ F4/80 ϩ cells.
Immunoblotting and Immunoprecipitation-BMDMs were serum-starved overnight, stimulated, and lysed in lysis buffer (150 mM NaCl, 50 mM HEPES (pH 7.4), 1 mM EDTA, 1% Nonidet P-40, protease inhibitors). Nuclear extracts or total cell lysates were immunoprecipitated with antibody-conjugated agarose. The resulting immunoprecipitates and lysates were subjected to SDS-PAGE and then blotted using antibodies.
Quantitative PCR-Total RNA was isolated using RNeasy kit (Qiagen) and reverse transcribed using SuperScriptIII (Invitrogen). Quantitative PCR was performed in triplicates using Power SYBR Green PCR Master Mix (Applied Biosystems). The amounts of transcript were normalized to GAPDH. Melting curves were run to ensure amplification of a single product. Primers were as follows: Mincle, 5Ј-AGTGCTCTCCTGGAC-GATAG-3Ј (forward) and 5Ј-CCTGATGCCTCACTGTAG-CAG-3Ј (reverse); GAPDH, 5Ј-AACAGCAACTCCCACTC-TTC-3Ј (forward) and 5Ј-CCTGTTGCTGTAGCCGTATT-3Ј (reverse).
ChIP Assay-The ChIP assay was performed with a ChIP kit (Upstate Biotechnology) as described previously (33, 34) . In brief, after cross-linking with 1% formaldehyde for 10 min at room temperature, cells were lysed in SDS buffer (50 mM Tris-Cl (pH 8.1), 10 mM EDTA, 1% SDS, and protease inhibitors). Lysates were sonicated using Bioruptor and diluted with a ChIP dilution buffer (20 mM Tris-Cl (pH 8.1), 1 mM EDTA, 150 mM NaCl, and 0.3% Triton X-100). Lysates were then precleared with protein G beads and incubated with p65, NFAT-c1, or control rabbit IgG at 4°C overnight. Protein G agarose was added to the lysates and incubated for 2 h at 4°C. Ab-protein-DNA complexes were eluted and incubated at 65°C overnight to reverse formaldehyde cross-linking, and DNA was recovered by a PCR purification kit (Clontech). DNA fragments were amplified by RT-PCR with specific primers. The antibodies used for ChIP are as follows: NFB-p65 (sc-109) and NFATc1 (sc-7294). The ChIP PCR primers were as follows: 5Ј-CAG-TGACAACTCAACCAAGC-3Ј (forward) and 5Ј-GAGGTTA-TGAGTGTCAGGAG-3Ј (reverse); 5Ј-ATGGCTCCTGCCA-CATATGT-3Ј (forward) and 5Ј-ACTCCATTCCCTCACTA-CTC-3Ј (reverse).
Luciferase Reporter Assay-The Mincle promoter was amplified by PCR using the genome DNA of wild type C57BL/6 mice as a template. PCR primers were as follows: 1783F, 5Ј-GACT-GACGCGTGGTTTGCAGCCCCATAGGAG-3Ј (forward); 1207F, 5Ј-GCGAGACGCGTGGTTTGGATCTTGGAAATG-ATG-3Ј (forward); 835F, 5Ј-TTGTGACGCGTATGTGTAG-CACTTCTATCTCCTGAC-3Ј (forward); and 5Ј-GATAAAG-ATCTAAGAGCCCCTGGAAAGTGAGT-3Ј (reverse). The two NF-kB-binding sites were mutated by site-directed mutagenesis. The primers are as follows: m1, 5Ј-TGAGCACTAGAGTGA-ATCTGTGGAAATAATAGAAAGTTTCCTTGAGGCA-3Ј (forward) and 5Ј-TCCACAGATTCACTCTAGTGCTCAGA-ACTTTTTATTTTACAGACACGTGGAT-3Ј (reverse); m2, 5Ј-TCATCAAACACCACTAGAGTGAAGTCATATGTGT-AGCACTTCTATCTCCTGAC-3Ј (forward) and 5Ј-TGAC-TTCACTCTAGTGGTGTTTGATGAGCCAGATTTCCTA-TGTGCTAC-3Ј (reverse). All of the reporter constructs were cloned into PGL3 luciferase reporter plasmid. RAW264.7 cells were transfected with different luciferase reporter constructs together with a Dectin-3 expression plasmid (pRV3-Dectin-3) and a control Renilla luciferase reporter plasmid by using a Neofect TM DNA transfection reagent Kit (catalog no. TF201201) according to manufacturer's instructions. The Dual-Luciferase reporter system (Promega) was used to examine firefly and Renilla luciferase activity. Renilla luciferase was used to normalize transfection efficiency and luciferase activity.
Cytokine Measurements-TNF-␣, IL-6, IL-1␤, and IL-10 levels in the supernatant of the cells were measured with Ready-SET-GO enzyme-linked immunosorbent assay (ELISA) kits (eBioscience). All samples were measured in triplicate according to the manufacturer's protocol.
Statistical Analysis-At least two biological replicates were performed for all experiments unless otherwise indicated. Student's t test for paired observations was used for statistical analyses. Statistical significance was set at a p value of Ͻ0.05 or 0.01.
RESULTS

Dectin-3 Is Necessary for TDM-induced Mincle Expression-
Recent studies suggest that Dectin-3/MCL functions as a pattern recognition receptor for TDM, and stimulation of Dectin-3 by TDM induces the expression of Mincle (25) . To confirm this result, BMDMs isolated from wild type or Dectin-3 knock-out mice were stimulated with plate-bound TDM, and then Mincle expression was determined. Consistent with a recent study, the TDM-induced Mincle expression both at protein ( Fig. 1A ) and mRNA levels ( Fig. 1B) was impaired in Dectin-3-deficient cells. Because our recent studies suggest that Dectin-3 and Dectin-2 form a heterodimeric receptor for sensing fungal infection (24), we examined whether Dectin-2/Dectin-3 heterodimers were involved in sensing TDM. BMDMs were pretreated with neutralizing antibodies against Dectin-3 or Dectin-2 to block the expression of Dectin-3 or Dectin-2 (24) . Consistent with what we observed in Dectin-3 knock-out BMDMs, Dectin-3-blocking antibodies effectively blocked TDM-induced Mincle expression ( Fig. 1C ). However, Dectin-2 antibodies were not able to block this induction of Mincle expression both at mRNA and protein level ( Fig. 1, D and E) , although Dectin-2 expression was blocked very efficiently ( Fig. 1E ). These results indicate that TDM only activates receptor containing Dectin-3 but not both Dectin-2 and Dectin-3, suggesting that the Dectin-3, but not Dectin-2/ Dectin-3 heterodimer, is a pattern-recognition receptor for TDM.
Dectin-3 Is Required for TDM-induced NF-B Activation-To determine the role of Dectin-3 after TDM stimulation, we examined the impact of Dectin-3 deficiency on TDM-induced signaling. We found that TDM-induced IKK phosphorylation, IB␣ degradation ( Fig. 2A ), and p65 subunit nuclear translocation were defective in Dectin-3-deficient BMDMs following stimulation by TDM ( Fig. 2B ). Moreover, there is also a significant reduction of nuclear NFAT-c1 ( Fig. 2B ). However, TDMinduced activation of p38, ERK, and JNK were comparable in WT and Dectin-3-deficient BMDMs (Fig. 2C ), indicating that these kinases can be activated by other receptors on BMDMs in response to TDM stimulation. Consistently, when Dectin-3 expression was blocked with neutralizing antibody, both ␣-mannan and TDM stimulation cannot induce p65 subunit nuclear translocation. However, blocking of Dectin-2 expression impaired the p65 translocation only when stimulated with ␣-mannan, but not in the TDM stimulation case (Fig. 2D ). This indicates that TDM only activates Dectin-3, whereas Dectin-2 is not necessary for NF-B activation. Moreover, the expression levels of proinflammatory cytokines including TNF-␣, IL-6, and IL-1␤ in Dectin-3-deficient BMDMs were also significantly reduced in comparison with those in WT cells ( Fig. 2E ). Taken together, these results demonstrate that Dectin-3 mediates TDM-induced NF-B activation.
NF-B, but Not NFAT, Is Required for Mincle Induction-To determine whether Dectin-3-induced Mincle expression is through NF-B-dependent mechanism, we used TPCA-1, an inhibitor for IKK, to inhibit NF-B activation (Fig. 3, A and C) and then examined the expression level of Mincle. We found
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that Mincle expression level is significantly reduced with this inhibitor both at protein (Fig. 3A ) and mRNA level (Fig. 3C ). Because NFAT-c1 is also affected in Dectin-3-deficient cells, we used NFAT inhibitor, 11R-VIVIT, with TDM stimulation. However, we found that inhibition of NFAT did not affect Mincle expression ( Fig. 3, B and C) . Consistently, we found that TPCA-1 inhibited TDM-induced expression of TNF␣ and IL-6, but not IL-10 expression ( Fig. 3D) . In contrast, NFAT inhibitor 11R-VIVIT could significantly reduce IL-10 expression ( Fig.  3D) as expected, but slightly influenced TNF␣ and IL-6 production. These results show that NF-B but not NFAT activation is essential for Mincle induction.
As three predicted NF-B-binding sites were found on Mincle promoter: Ϫ1589, Ϫ941, and Ϫ851 (Fig. 4A ), we hypothesize that NF-B may directly regulate Mincle expression through binding to its promoter following TDM stimulation. To test this hypothesis, we performed ChIP assay and found that there was a strong binding of NF-B p65 subunit on Mincle promoter in control cells after 2 hour stimulation with TDM. However, there is almost no p65 binding in Dectin-3-deficient cells. Moreover, NFAT-c1 cannot bind with Mincle promoter after TDM stimulation neither in control cells nor in Dectin-3-deficient cells (Fig. 4B ). To further test whether NF-B dictates transcription of Mincle genes, luciferase reporter assay and NF-B binding sites mutation was performed. The Mincle pro-moter activation exhibited substantially increase whether the Ϫ1589 site was present or not ( Fig. 4C ). However, mutation of either Ϫ941 or Ϫ851 site severely impaired Mincle promoter activation, which is consistent with the impaired activation by deletion of all three NF-B binding sites (Fig. 4C) . These results clearly demonstrate that NF-B regulates Mincle expression through directly activating its promoter, and both NF-B binding site Ϫ941 and Ϫ851 are necessary. Together, our results indicate that Dectin-3-mediated NF-B activation is necessary for TDM-induced Mincle expression.
Dectin-3 and Mincle Neither Form a Heterodimeric Receptor Nor Synergistically Induce Signaling-Our recent studies have found that Dectin-3 forms heterodimers with Dectin-2, another C-type lectin receptor, which provides a high sensitivity for recognition of the cell wall component of Candida albicans (24) . Because both Dectin-3 and Mincle can respond to TDM stimulation, we examine whether Dectin-3 and Mincle can form a heterodimer and function synergistically. To examine whether Dectin-3 and Mincle form heterodimers, RAW264.7 cells stably expressing Mincle, Dectin-3, or both were stimulated with TDM and then immunoprecipitated with Dectin-3 or Mincle. In contrast with Dectin-2 and Dectin-3, Dectin-3 and Mincle were not co-immunoprecipitated when they were co-expressed in RAW264.7 cells (Fig. 5A) . These results indicate that Dectin-3 and Mincle are not physically linked. 
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To determine whether Dectin-3 and Mincle can work synergistically to induce NF-B activation and cytokine expression, RAW264.7 cells stably expressing Mincle, Dectin-3, or both were stimulated with TDM, and then p65 nuclear translocation was examined. We found that there was no obvious difference for p65 nuclear translocation no matter Dectin-3 and Mincle were co-expressed or not (Fig. 5B) , and the expression of proinflammatory cytokines such as TNF␣ and IL-6 did not have significantly difference between Dectin-3 or Mincle alone and Mincle/Dectin-3 co-expression ( Fig. 5C ). Taken together, these results indicate that unlike Dectin-2/Dectin-3 heterodimers, Dectin-3 and Mincle neither form heterodimers nor work synergistically to activate NF-B.
Dectin-3 Serves as a Sensor for Mincle Induction-To determine the role of Dectin-3 for sensing TDM, we treated BMDMs with Dectin-3 antibodies, which can induce Dectin-3 endocytosis (24) , before (Fig. 6A , Preϩa-D3) or after TDM treatment for 3 h (Fig. 6A, 3 hϩa-D3 ). As expected, pretreatment with Dectin-3 antibodies could sufficiently impair Mincle induction (Fig. 6B ). However, after TDM stimulation for 3 h, blocking Dectin-3 no longer affected Mincle induction at all (Fig. 6B ), which indicates that Mincle was already induced in the first 3-h treatment, and TDM could induce Mincle expression through stimulating Mincle itself. Consistent with this result, TNF␣ and IL-6 production were not affected when we blocked Dectin-3 expression 3 h after TDM stimulation (Fig. 6, C and D) . Together, these results indicate that Dectin-3 serves as a sensor for TDM when Mincle level is low. However, once Mincle is induced, Dectin-3 is not required for further expression of Mincle and cytokines.
CARD9, Bcl10, and Malt1 Are Required for Mincle Induction Following TDM Stimulation-It has been shown that the CARD9-Bcl10-Malt1 complex is necessary for NF-B activation upon different stimulation. Recent study shows that CARD9-dependent pathway plays important roles in TDM-induced inflammation and Th17 response (15) . Therefore, we examined whether the CARD9-Bcl10-Malt1 complex is required for TDM-induced Mincle expression. To test this hypothesis, CARD9-deficient BMDMs were prepared from CARD9 knock-out mice. Then, these cells were stimulated with FIGURE 2. Dectin-3 is required for TDM-induced NF-B activation. A-C, BMDMs from WT and Dectin-3 KO mice were either untreated or stimulated with plate-coated TDM for indicated time points. A, total cell lysates were prepared from these cells and then subjected to immunoblotting analysis using indicated antibodies. B, nuclear extracts were prepared and analyzed by immunoblotting with p65, NFAT-c1, and proliferating cell nuclear antigen antibodies. C, immunoblotting with the indicated antibodies were done with the total cell lysates. D, BMDMs from WT mice were pretreated with Dectin-2 or Dectin-3 blocking antibodies for 45 min. Resulting cells were stimulated with plate-coated ␣-mannan (man) or TDM for 1 h. Nuclear extracts were prepared and analyzed by immunoblotting with p65 and proliferating cell nuclear antigen (PCNA) antibodies. Total cell lysates were immunoblotting with Dectin-2 or Dectin-3 antibodies. E, ELISA results for TNF-␣, IL-6, and IL-1␤ in supernatants of BMDMs derived from WT or Dectin-3 KO mice, which were stimulated with plate-coated TDM for 8 h. Data shown are representative of three independent experiments. S.D. is indicated. **, p Ͻ 0.01 (t test). Ctr, control. 
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TDM for different time points. We found that although wild type and CARD9-deficient cells expressed comparable level of Dectin-3, Mincle induction was severely impaired in CARD9deficient cells at both protein and mRNA level (Fig. 7, A and C) . We then checked whether Bcl10 or Malt1 is required for the Mincle induction using BMDMs from Bcl10 or Malt1 knockout mice and found that both Bcl10 and Malt1 were required for TDM-induced Mincle expression ( Fig. 7, B and D) . Moreover, TDM-induced proinflammatory cytokine, TNF, IL-6, and IL-1␤ were also significantly reduced in these CARD9-, Bcl10-, or Malt1-deficient cells (Fig. 7E) . These results demonstrate that NF-B activation is necessary for TDM-induced Mincle expression in a CARD9/Bcl10/Malt1-dependent manner.
Dectin-3 and CARD9 Deficiency Significantly Affect TDMmediated Adjuvant Function-TDM, also known as cord factor, is a Mycobacterium glycolipid with potent adjuvant activity.
To determine whether Dectin-3 and CARD9 could account for the adjuvant activity, complete Freund's adjuvant a waterin-oil emulsion containing heat-killed Mycobacterium tuberculosis, together with an immune antigen, KLH, were used to immunize Dectin-3 or CARD9 knock-out mice. Forty-eight hours after immunization, serum was taken to measure the cytokine production. TNF and IL-6 concentration both were significant lower in Dectin-3 and CARD9 knock-out mice (Fig.  8A) . Seven days after immunization, KLH-specific antibody pro-duction was determined. We found that Dectin-3 and CARD9 knock-out mice showed significant less IgG (both IgG1 and IgG2a) and IgM production ( Fig. 8B ). Together, these results indicated that Dectin-3 and CARD9 are required for adaptive immune response when TDM-containing adjuvant is used.
DISCUSSION
Dectin-3, a CLR, has been shown to function as a pattern recognition receptor for Mycobacterium glycolipid, TDM, and stimulation of Dectin-3 by TDM induces the expression of another CLR, Mincle (25) . It has been shown that Mincle also plays a critical role for TDM-induced proinflammatory and adjuvant responses (7, 8) . Therefore, it is critical to determine the molecular mechanism of the functional connection between Dectin-3 and Mincle. In this study, we have shown that Dectin-3 serves as a molecular sensor for recognition of TDM, which leads to induction of Mincle expression ( Fig. 9 ). The Dectin-3-induced Mincle expression is directly regulated by transcription factor NF-B that is activated through a signaling pathway dependent on CARD9, Bcl10, and Malt1. Consistently, we have found that Dectin-3-and CARD9-deficient mice produce much less amount of proinflammatory cytokines and antigen-specific antibodies when immunized with adjuvant containing TDM. Together, our study provides the molecular 
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A recent report by Lobato-Pascual et al. (26) described a receptor complex formed by Mincle with Dectin-3 and Fc⑀RI-␥, and this association enhanced phagocytosis of antibody-coated beads. However, in our study, we could not detect the heterodimeric complex of Dectin-3 and Mincle when they were co-expressed in mouse macrophage-like cells, RAW264.7 cells. The most possible explanation for the discrepancy between Lobato-Pascual's results and our results could be due to the expression level of Dectin-3 and Mincle in rat cells used by Lobato-Pascual et al. (26) versus mouse cells used in our study. However, co-expression of Dectin-3 and Mincle cannot synergistically induce NF-B activation and cytokine expression, which was found upon co-expression of heterodimeric complexes of Dectin-2 and Dectin-3 (24) . Moreover, there is no evidence that endogenous Dectin-3 and Mincle can form heterodimeric complexes (26) .
TDM promotes both normal innate and acquired immunity and contributes to immune disorders such as granuloma for-mation (2) and experimental autoimmune encephalomyelitis (15, 16) . Consistently, Dectin-3-deficient mice have defect in both innate and adaptive immune response (4, 24, 25) . However, TDM-induced adaptive immune response was almost completely dependent on Dectin-3, but not Mincle (25) , demonstrating that Dectin-3 plays important roles for TDM-induced innate immune response.
We have shown that Dectin-3 induces NF-B activation in response to C. albicans hyphae challenging (24) and have found that a portion of Dectin-3 forms heterodimers with another CLR Dectin-2, which has a higher affinity recognizing ␣-mannan on the cell wall of C. albicans, and potently induces proinflammatory response to the fungal infection (24) . However, unlike Dectin-2/Dectin-3 heterodimers, we have found that Dectin-3 and Mincle neither form heterodimers nor synergistically regulate NF-B activation together with Dectin-3 upon TDM stimulation. Instead, Dectin-3 and Mincle function in a sequential cascade to provide an amplification loop to enhance TDM-induced proinflammatory response (Fig. 9 ). In this case, FIGURE 8 . Dectin-3-and CARD9-deficient mice produce much less cytokine and antibodies upon immunization using adjuvant containing TDM. CARD9-and Dectin-3-deficient mice and their controls were immunized with KLH emulsified in complete Freund's adjuvant at the base of the tail. A, forty-eight hours later, blood was collected from the tail and measured with ELISA for TNF␣ and IL-6 production. **, p Ͻ 0.01 (t test). B, seven days after immunization, sera from the indicated immunized mice were subjected to serial dilutions, and the concentrations of KLH-specific IgG and IgM antibodies were analyzed by ELISA and averaged for each group. Graphs show the means Ϯ S.D. from three mice of each genotype.
Dectin-3 is only necessary for the initial induction of Mincle expression. After the initial stimulation of Dectin-3 and induction of Mincle expression, blocking Dectin-3 no longer influences the further induction of Mincle expression. These results indicate that Decin-3 serves as the initial sensing molecule for recognition of TDM and induces expression of Mincle through activation of NF-B. Once Mincle level is induced, Mincle can further regulate its own expression ( Fig. 9 ).
NFAT is another transcription factor that may be involved in regulation of Dectin-3-induced Mincle expression because there is defect for NFAT-c1 translocation in Dectin-3-deficient cells upon TDM stimulation (25) . However, treatment of BMDMs with 11R-VIVIT, a well characterized NFAT inhibitor did not affect TDM-induced Mincle expression, although this inhibitor could efficiently block NFAT-c1 translocation (data not shown) and subsequently IL-10 production. Consistently, we were unable to detect the binding of NFAT-c1 to Mincle promoter as NF-B does. Together, these results indicate that Dectin-3-induced Mincle expression is regulated by transcription factor NF-B but not NFAT.
In summary, our study provides the genetic and biochemical evidence for the molecular link between Dectin-3 and Mincle in response to TDM stimulation. We have demonstrated that Dectin-3 functions as a sensing molecule for detecting low level of TDM molecule, which leads to the induction of Mincle expression by activating NF-B through CARD9-Bcl10-Malt1 complex-dependent mechanism. The induced Mincle can also recognize TDM and further amplifies the response to induce strong innate immune and inflammatory response.
